Mojca Stegnar

1.6k citations

75 papers · 1.3k indexed · h-index 20

Impact in

Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms

Papers in ⓘ

Hematology 23
- Blood Coagulation and Thrombosis Mechanisms 18
Internal Medicine 20
- Venous Thromboembolism Diagnosis and Management 20

Co-authors: Polona Peternel (22 shared papers)Mojca Božič Mijovski (18 shared papers)D. Keber (15 shared papers)Vita Dolžan (4 shared papers)Katja Breskvar (4 shared papers)D. Kikelj (9 shared papers)Alenka Mavri (4 shared papers)Aleš Blinc (6 shared papers)
Journals: Thrombosis Research (13 papers)Thrombosis and Haemostasis (8 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)European Journal of Medicinal Chemistry (3 papers)
Partner nations: Slovenia Austria Poland

In The Last Decade

Mojca Stegnar

72 papers receiving 1.3k citations

Peers

Countries citing papers authored by Mojca Stegnar

Since Specialization

Citations

This map shows the geographic impact of Mojca Stegnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojca Stegnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojca Stegnar more than expected).

Fields of papers citing papers by Mojca Stegnar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mojca Stegnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojca Stegnar. The network helps show where Mojca Stegnar may publish in the future.

Co-authors

The 25 scholars most cited alongside Mojca Stegnar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mojca Stegnar Line = papers co-authored together Mojca Stegnar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose The Pharmacogenomics Journal ·Darja Herman, Igor Locatelli, Iztok Grabnar, Polona Peternel, Mojca Stegnar, Aleš Mrhar, Katja Breskvar, Vita Dolžan	2005	103
2	The influence of sequence variations in factor VII, γ-glutamyl carboxylase and vitamin K epoxide reductase complex genes on warfarin dose requirement Thrombosis and Haemostasis ·Darja Herman, Polona Peternel, Mojca Stegnar, Katja Breskvar, Vita Dolžan	2006	96
3	Impact of Adipose Tissue on Plasma Plasminogen Activator Inhibitor-1 in Dieting Obese Women Arteriosclerosis Thrombosis and Vascular Biology ·Alenka Mavri, Mojca Stegnar, Michael Krebs, Jožica T. Sentočnik, Margarethe Geiger, B. R. Binder	1999	92
4	A NOVEL G/A AND THE 4G/5G POLYMORPHISM WITHIN THE PROMOTER OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN PATIENTS WITH DEEP VEIN THROMBOSIS Thrombosis Research ·Nelly Grubic, Mojca Stegnar, Polona Peternel, Alexandra Kaider, Bernd R. Binder	1996	73
5	3,4-Dihydro-2H-1,4-benzoxazine Derivatives Combining Thrombin Inhibitory and Glycoprotein IIb/IIIa Receptor Antagonistic Activity as a Novel Class of Antithrombotic Compounds with Dual Function Journal of Medicinal Chemistry ·Janez Ilaš, Žiga Jakopin, Tina Borštnar, Mojca Stegnar, D. Kikelj	2008	59
6	Toward a Novel Class of Antithrombotic Compounds with Dual Function. Discovery of 1,4-Benzoxazin-3(4H)-one Derivatives Possessing Thrombin Inhibitory and Fibrinogen Receptor Antagonistic Activities Journal of Medicinal Chemistry ·Marko Anderluh, Janez Ilaš, Janez Mravljak, Marija Sollner Dolenc, Mojca Stegnar, D. Kikelj	2005	49
7	D-dimer, other markers of haemostasis activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis Thrombosis Research ·Mojca Božič Mijovski, Aleš Blinc, Mojca Stegnar	2002	43
8	Fibrinolytic response to venous occlusion in healthy subjects: Relationship to age, gender, body weight, blood lipids and insulin Thrombosis Research ·Mojca Stegnar, M. Pentek	1993	43
9	Design and synthesis of novel platelet fibrinogen receptor antagonists with 2H-1,4-benzoxazine-3(4H)-one scaffold. A systematic study European Journal of Medicinal Chemistry ·Marko Anderluh, Jožko Cesar, Petra Peharec Štefanić, D. Kikelj, Damjan Janeš, Jernej Murn, Kristina Nadrah, Mojca Tominc, Elisabeth Addicks, Athanassios Giannis, Mojca Stegnar, Marija Sollner Dolenc	2004	39
10	The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose European Journal of Clinical Pharmacology ·Darja Herman, Igor Locatelli, Iztok Grabnar, Polona Peternel, Mojca Stegnar, Mitja Lainščak, Aleš Mrhar, Katja Breskvar, Vita Dolžan	2006	37
11	Methyl-methacrylate bone cement surface does not promote platelet aggregation or plasma coagulation in vitro Thrombosis Research ·Aleš Blinc, Mojca Božič Mijovski, Rok Vengust, Mojca Stegnar	2004	30
12	Do baseline serum leptin levels predict weight regain after dieting in obese women? Diabetes Obesity and Metabolism ·Alenka Mavri, Mojca Stegnar, Mišo Šabović	2001	29
13	Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis Thrombosis Research ·Mojca Stegnar, Borut Božič, Polona Peternel, Tanja Kveder, Nina Vene, Blaž Rozman	1991	29
14	Factor V Leiden, prothrombin 20210G → A, methylenetetrahydrofolate reductase 677C → T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism European Journal of Obstetrics & Gynecology and Reproductive Biology ·Leon Meglič, Mojca Stegnar, Tomaž Milanez, Mojca Božič Mijovski, Borut Peterlin, Polona Peternel, Živa Novak‐Antolič	2003	29
15	Influence of Degraded Phosphatidylserine on Binding of Antiphospholipid Antibodies International Archives of Allergy and Immunology ·Borut Božič, Tanja Kveder, Mojca Stegnar, Evridika Morosini-Berus, M. Kos-Golja, Polona Peternel, Blaž Rozman	1997	27
16	Different Tissue Plasminogen Activator Release in the Arm and Leg during Venous Occlusion Is Equalized after DDAVP Infusion Thrombosis and Haemostasis ·D. Keber, Mojca Stegnar, Cornelis Kluft	1990	25
17	Influence of Moderate and Strenuous Daily Physical Activity on Fibrinolytic Activity of Blood: Possibility of Plasminogen Activator Stores Depletion Thrombosis and Haemostasis ·D. Keber, Mojca Stegnar, Irena Keber, B Accetto	1979	21
18	Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia Thrombosis Research ·Saša Anžej, Mojca Božič Mijovski, Aleksandra Antovič, Polona Peternel, Nataša Gašperšič, Uroš Rot, Gregor Tratar, Mojca Stegnar	2006	21
19	Do Haemostasis Activation Markers that Predict Cardiovascular Disease Exist? Pathophysiology of Haemostasis and Thrombosis ·Mojca Stegnar, Nina Vene, Mojca Božič Mijovski	2003	20
20	Major and Potential Prothrombotic Genotypes in Patients with Venous Thrombosis and in Healthy Subjects from Slovenia Pathophysiology of Haemostasis and Thrombosis ·Mateja Bedenčič, Mojca Božič Mijovski, Polona Peternel, Mojca Stegnar	2007	19

About Mojca Stegnar

Mojca Stegnar is a scholar working on Hematology, Internal Medicine, Surgery, Organic Chemistry and Cardiology and Cardiovascular Medicine, having authored 75 papers that have together received 1.3k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (20 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers), Blood properties and coagulation (11 papers), Chemical Synthesis and Analysis (8 papers), Synthesis and Characterization of Heterocyclic Compounds (8 papers), Protease and Inhibitor Mechanisms (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). The work is most often cited by research in Internal Medicine (234 citations), Hematology (321 citations), Pharmacology (209 citations), Cardiology and Cardiovascular Medicine (284 citations) and Cancer Research (151 citations). Mojca Stegnar has collaborated with scholars based in Slovenia, Austria and Poland. Frequent co-authors include Polona Peternel, Mojca Božič Mijovski, D. Keber, Vita Dolžan, Katja Breskvar, D. Kikelj, Alenka Mavri, Aleš Blinc, Nina Vene and Janez Ilaš. Their work appears in journals such as Thrombosis Research, Thrombosis and Haemostasis, Clinical Chemistry and Laboratory Medicine (CCLM), Bioorganic & Medicinal Chemistry Letters and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact